Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION (NDC 7995211001) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 24, 2026 , from http://ppman.hank.ai/transparency/procedure/7995211001/by-state?code_type=NDC
“LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION (NDC 7995211001) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/7995211001/by-state?code_type=NDC. Accessed
October 24, 2026 .
“LONCASTUXIMAB TESIRINE-LPYL 10 MG INTRAVENOUS SOLUTION (NDC 7995211001) by State,” HANK Price Transparency ,
accessed October 24, 2026 ,
http://ppman.hank.ai/transparency/procedure/7995211001/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
7995211001 — Loncastuximab Tesirine-lpyl 10 Mg Intravenous Solution
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$592
National median
$225 – $16,075
IQR (p25 – p75)
7
hospitals filing
2
states
Walking in without insurance?
Cash / self-pay price
Cash median
$14,947
vs. negotiated
+2426.3%
Hospitals reporting
7
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 7995211001 (NDC), with interquartile range
State Median p25 p75
VA $27,225 $17,162 $44,182
PA $241 $221 $746